The Technical Analyst
Select Language :
Novocure Ltd [NVCR]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Instruments & Supplies

Novocure Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Novocure Ltd is listed at the  Exchange

6.76% $15.63

America/New_York / 28 mar 2024 @ 16:00


FUNDAMENTALS
MarketCap: 1 673.86 mill
EPS: -1.950
P/E: -8.02
Earnings Date: Jan 08, 2024
SharesOutstanding: 107.09 mill
Avg Daily Volume: 1.383 mill
RATING 2024-03-28
B+
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Strong Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -8.02 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.24x
Company: PE -8.02 | industry: PE 33.06
DISCOUNTED CASH FLOW VALUE
$2.58
(-83.50%) $-13.05
Date: 2024-03-29
Expected Trading Range (DAY)

$ 14.65 - 16.61

( +/- 6.27%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-01 Groenhuysen Wilhelmus Cm Sell 2 107 Ordinary Shares
2024-03-04 Groenhuysen Wilhelmus Cm Sell 1 217 Ordinary Shares
2024-03-01 Leonard Frank X Sell 1 679 Ordinary Shares
2024-03-04 Leonard Frank X Sell 840 Ordinary Shares
2024-02-27 Cordova Ashley Buy 102 249 Ordinary Shares
INSIDER POWER
77.53
Last 92 transactions
Buy: 1 705 026 | Sell: 238 995

Forecast: 16:00 - $15.62

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $15.62
Forecast 2: 16:00 - $15.62
Forecast 3: 16:00 - $15.62
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $15.63 (6.76% )
Volume 2.40 mill
Avg. Vol. 1.383 mill
% of Avg. Vol 173.81 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Novocure Ltd

Last 12 Months

Last 12 months chart data with high, low, open and close for Novocure Ltd

RSI

Intraday RSI14 chart for Novocure Ltd

Last 10 Buy & Sell Signals For NVCR

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:36sell$14.68N/AActive
Profile picture for
            Novocure Ltd

NVCR

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Last 10 Buy Signals

Date Signal @
XCHUSDMar 29 - 03:42$40.67
SFUNDUSDMar 29 - 03:41$4.51
SXPUSDMar 29 - 03:41$0.483
STRAXUSDMar 29 - 03:40$0.138
MINAUSDMar 29 - 03:42$1.230
POLSUSDMar 29 - 03:41$1.200
GNOUSDMar 29 - 03:42$359.89
BSVUSDMar 29 - 03:42$92.86
ASTRUSDMar 29 - 03:420.138
XTZUSDMar 29 - 03:40$1.407

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.